Related Experiment Video
Updated: Jun 19, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Endocrine disruption and ovarian morphometric responses in rats following exposure to tetradifon
Riadh Badraoui1, Nouha B Abdelmoula, Nozha Feki
1Laboratory of Histology, Medicine Faculty of Sfax, 3029 Sfax, Tunisia. riadh.badraoui@etud.univ-angers.fr
Abstract:
We have investigated whether exposure to tetradifon causes ovary injuries, disrupts folliculogenesis in rat and whether ovary hormones (estrogen and progesterone) to be affected by this endocrine-active agent. Female rats were exposed orally to a dose of 28.9 mg/kg/day for 6 or 12 weeks. After sacrifice, ovary glands were examined for morphometric changes. The serums were used to determine levels of 17beta-estradiol and progesterone. Results showed no sign of toxicity. However, tetradifon promoted a significant increase in the percentage of atretic follicles in the 12-weeks treated rats. Number and the diameter of mature follicles (tertiary and preovulatory) were markedly diminished together with a reduction of the relative weight of ovaries. Compared with controls, the treated rats exhibited significant reduction in serum 17beta-estradiol and progesterone levels. These results suggest an endocrine disruption by tetradifon which may interfere with ovarian follicles development in rat.
Related Concept Videos
Teratogenicity
Toxicity Testing in Animals

